Skip to content

The effect of silymarin on methadone poisoning

Evaluation of the therapeutic effect of Silymarin in combination with naloxone in improving methadone poisoning

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210216050377N1
Enrollment
64
Registered
2022-01-16
Start date
2021-05-19
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poisoning by methadone. Poisoning by methadone, undetermined

Interventions

Intervention 1: Control group:This group includes people who have been exposed to methadone poisoning and have referred to Ayatollah Kashani Hospital in Shahrekord and have the inclusion criteria and

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with opioid triad include decreased level of consciousness, myotic pupil and decreased level of blood oxygen Methadone level is positive in their urine test (U / A)

Exclusion criteria

Exclusion criteria: Patient dissatisfaction to participate in the study Use of supplements and drugs with similar effects or interventions with Naloxone and Silymarin

Design outcomes

Primary

MeasureTime frame
Serum level of Aspartate transaminase. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyzer.;Serum level of Alanine transaminase. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Blood urea nitrogen. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Creatinine. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Uric Acid. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Lactate dehydrogenase. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Creatine phosphokinase. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention with silymarin. Method of measurement: They are measured on serum by commercial kits of Pars Azmoun company Italian BT3000 auto analyze.;Serum level of Sodium. Timepoint: Measurement of the variable before the intervention and 3 days after the intervention

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPantea Ramezan Nezhad

Shahre-kord University of Medical Sciences

ramezannezhad.p@skums.ac.ir0983832264825

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026